rethinkPeptides Search
Menu
Research citation

GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations.

Expert opinion on drug metabolism & toxicology, 9(1), 17-29

Citation

Jespersen, Maria J; Knop, Filip K; Christensen, Mikkel. (2013). GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations.. Expert opinion on drug metabolism & toxicology, 9(1), 17-29. https://doi.org/10.1517/17425255.2013.731394